DESIGN AND CHARACTERIZATION OF ATENOLOL NANOSTRUCTURED LIPID CARRIERS FOR ORAL ADMINISTRATION

The present study aimed to design and characterize Atenolol loaded Nanostructured Lipid Carriers (NLCs) to enhance permeation and bioavailability. Atenolol, a BCS Class III drug with high solubility and low permeability, was incorporated into Nanostructured lipid carriers using the Solvent evaporation method. A Central Composite Design (CCD) was employed to optimize the formulation variables, including solid lipid and surfactant concentrations. The optimized formulation (F14) was evaluated for entrapment efficiency, particle size, zeta potential, in-vitro drug release, and morphology. The optimized NLCs formulation exhibited an entrapment efficiency of 83.93%, a drug release of 74.7% at 8 hours, and uniform vesicle morphology under SEM. The optimized NLCs were successfully incorporated into controlled release capsules, evaluation parameters were within pharmacopeial limits. The controlled release profile of the optimized capsules suggests the potential and achieve better blood pressure control. Overall, the study demonstrates that Atenolol-loaded NLCs are a promising strategy to improve bioavailability, reducing first-pass metabolism, controlled drug release, and provide an effective oral dosage form for hypertension management.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-17
DOI
https://doi.org/10.5281/zenodo.24300927
Primary Topic
Drug Solubulity and Delivery Systems
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

DESIGN AND CHARACTERIZATION OF ATENOLOL NANOSTRUCTURED LIPID CARRIERS FOR ORAL ADMINISTRATION

J Adlin Jino Nesalin, Ganesh N.S, Manjushree P. R.
1 links
Zenodo (CERN European Organization for Nuclear Research)
Drug Solubulity and Delivery Systems
article

DESIGN AND CHARACTERIZATION OF ATENOLOL NANOSTRUCTURED LIPID CARRIERS FOR ORAL ADMINISTRATION

J Adlin Jino Nesalin, Ganesh N.S, Manjushree P. R.
article en

Abstract

The present study aimed to design and characterize Atenolol loaded Nanostructured Lipid Carriers (NLCs) to enhance permeation and bioavailability. Atenolol, a BCS Class III drug with high solubility and low permeability, was incorporated into Nanostructured lipid carriers using the Solvent evaporation method. A Central Composite Design (CCD) was employed to optimize the formulation variables, including solid lipid and surfactant concentrations. The optimized formulation (F14) was evaluated for entrapment efficiency, particle size, zeta potential, in-vitro drug release, and morphology. The optimized NLCs formulation exhibited an entrapment efficiency of 83.93%, a drug release of 74.7% at 8 hours, and uniform vesicle morphology under SEM. The optimized NLCs were successfully incorporated into controlled release capsules, evaluation parameters were within pharmacopeial limits. The controlled release profile of the optimized capsules suggests the potential and achieve better blood pressure control. Overall, the study demonstrates that Atenolol-loaded NLCs are a promising strategy to improve bioavailability, reducing first-pass metabolism, controlled drug release, and provide an effective oral dosage form for hypertension management.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Drug Solubulity and Delivery Systems
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon